British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
Begin your TipRanks Premium journey today. GlaxoSmithKline (GSK) Company Description: In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales.
This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...
Begin your TipRanks Premium journey today. GlaxoSmithKline (GSK) Company Description: In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales.
GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...
GSK signs AllTrials data transparency campaign In an unusual development, one day after the Pharmaceutical Research &amp, Manufacturers of America trade group in the US harshly criticized a call ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Meanwhile, GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK), a global biopharma company, recently launched a new vaccine called Shingrix to prevent shingles. Shingrix is also known as Recombinant Zoster ...
Bonus Sep 11, 2018 Sep 13, 2018 Jul 24, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jan 02, 1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, ...
Credit: CeltStudio/Shutterstock. Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted for review GSK's new drug application (NDA) for Blenrep (belantamab mafodotin) to treat patients ...
The MHLW also granted orphan drug designation to Blenrep for multiple myeloma indication. Credit: CeltStudio/Shutterstock. Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review ...